MedPage Today on MSN

Longer lytic-PCI window; virtual heart teams; large vessel occlusion blood test?

Recent developments of interest in cardiovascular medicine ...

Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 MDA Clinical and Scientific Conference, long-term data from its MESA ...